PTGX icon

Protagonist Therapeutics

166 hedge funds and large institutions have $1.57B invested in Protagonist Therapeutics in 2023 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 48 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

23% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 48

22% more funds holding

Funds holding: 136166 (+30)

4.67% less ownership

Funds ownership: 103.77%99.1% (-4.7%)

Holders
166
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$49.7M
Puts
$22.8M
Net Calls
Net Calls Change

Top Buyers

1 +$52.4M
2 +$45.8M
3 +$31.4M
4
RI
RTW Investments
New York
+$22.5M
5
Holocene Advisors
Holocene Advisors
New York
+$22.2M

Top Sellers

1 -$34.9M
2 -$33.2M
3 -$27.4M
4
Millennium Management
Millennium Management
New York
-$21.3M
5
Citadel Advisors
Citadel Advisors
Florida
-$17M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$150M
2
$138M
3
$125M
4
$104M
5
$98.1M
6
$86.9M
7
$67.6M
8
$45.8M
9
$41.4M
10
$40.6M
11
$35.7M
12
$29.8M
13
$28.7M
14
$26.9M
15
$25.9M
16
$23.8M
17
$23M
18
$22.5M
19
$22.2M
20
$21M
21
$20M
22
$16M
23
$15.7M
24
$15.4M
25
$15.2M